Cargando…
Hypertension and COVID-19: Ongoing Controversies
Coronavirus disease 2019 (COVID-19) has become a worldwide pandemic responsible for millions of deaths around the world. Hypertension has been identified as one of the most common comorbidities and risk factors for severity and adverse outcome in these patients. Recent investigations have raised the...
Autores principales: | Tadic, Marijana, Saeed, Sahrai, Grassi, Guido, Taddei, Stefano, Mancia, Giuseppe, Cuspidi, Cesare |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925389/ https://www.ncbi.nlm.nih.gov/pubmed/33681308 http://dx.doi.org/10.3389/fcvm.2021.639222 |
Ejemplares similares
-
COVID‐19 and arterial hypertension: Hypothesis or evidence?
por: Tadic, Marijana, et al.
Publicado: (2020) -
White-Coat Hypertension: the Neglected Subgroup in Hypertension
por: Cuspidi, Cesare, et al.
Publicado: (2018) -
COVID-19, hypertension and cardiovascular diseases: Should we change the therapy?
por: Tadic, Marijana, et al.
Publicado: (2020) -
Isolated Nocturnal Hypertension: What Do We Know and What Can We Do?
por: Tadic, Marijana, et al.
Publicado: (2020) -
New antidiabetic therapy and HFpEF: light at the end of tunnel?
por: Tadic, Marijana, et al.
Publicado: (2021)